Several posters presented at the American Academy of Dermatology Annual Meeting explored the topic of skin tone bias related to vitiligo in Google and internet search platforms.
Paul Friedman, MD, discusses the benefits of UltraClear Laser-Coring, patient downtime, how to decide what devices to have in your clinic, and more.
How can you improve excision care for your patients with hidradenitis suppurativa? Ashley Nicole Elsensohn, MD, MPH, FAAD, shared clinical pearls at the AAD Annual Meeting.
Balancing ethics, aesthetics, and patient expectations is crucial in dermatology to ensure safe, responsible, and ethical care.
Fixed-annuity guarantees more income for penalty-free early withdrawals from retirement plans.
The COVID-19 pandemic reshaped dermatology through telehealth, social media, and increased cosmetic procedures. Challenges and opportunities persist as practices adapt.
Nitin Joshi, PhD, shared CAGE Bio’s development of CGB-500 and why phase 2 EASI scores have the company’s scientific advisory board optimistic.
Dermatology physician associates via DPAF conduct skin checks at the Sun Bus during the Fall Conference.
Harnessing digital marketing tools can help your medical practice grow.
Alexandra P. Charrow, MD, FAAD, shares insights on the link between dermatology and irritable bowel disease at the AAD Annual Meeting.
Sydney Givens, PA-C, reviews how she discusses cosmeceuticals with her patients and what resources she offers.
The co-founder of PathAI and its PathAssist Derm tool believes AI is going to be incredibly valuable for dermatologists and dermatopathologists.
Enhanced education can reduce uncertainty among both patients and providers, with pharmacists playing a key role as primary sources of patient information.
Facial hyperpigmentation may signal systemic disease. Dermatologists must assess beyond melasma to ensure timely, accurate diagnosis and care.
VYNE recently announced positive results for its novel oral small molecule BD2-selective BET inhibitor in a single-ascending dose clinical trial.
Immunotherapy agent nemvaleukin alfa was granted an FDA fast track designation for the treatment of patient’s mucosal melanoma for previously undergone treatment with an anti-PD-L1 therapy.
Founder Dina El-Sherif, MBA, gave an in-depth overview of the at-home facial rejuvenation device and its 3-step process at AAD 2024.
Miiskin is transforming dermatologic care through telehealth, enhancing access, efficiency, and patient relationships, according to Ryan Trowbridge, MD, MS, MA, FAAD.
Discover promising advancements in vitiligo treatments, including innovative therapies and combination approaches that enhance skin repigmentation and improve patient quality of life.
Gold highlighted the growing role of energy-based devices in acne treatment during his AAD session.
“As good as we saw results in 1 month, we think we'll see even more remarkable results over the 6 months of treatment,” Edelson said in an interview with Dermatology Times.
In one-third of cases of psoriasis, disease onset occurs in the first or second decade of life, although it may not be diagnosed until the patient has reached adulthood.
Diego Ruiz Dasilva, MD, FAAD, reviews the unmet needs and barriers in the treatment landscape of atopic dermatitis.
It effects most teenagers and can lead to mental distress. Here are 5 important facts about acne vulgaris in adolescents.
Sexual and gender minority patients with chronic inflammatory skin diseases may be disproportionately influenced by cost and noncost obstacles to health care.